Naprosyn and Piroxicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naprosyn (naproxen) and Piroxicam (piroxicam). Common drug interactions include pericardial effusion among females and ankylosing spondylitis among males.

The phase IV clinical study analyzes what interactions people have when they take Naprosyn and Piroxicam. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Piroxicam?

Piroxicam has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 8,582 Piroxicam users. Check the latest studies of Piroxicam.



On Jul, 13, 2026

38 people who take Naprosyn and Piroxicam together, and have interactions are studied.

Naprosyn and Piroxicam drug interactions.

What are the common drug interactions of Naprosyn and Piroxicam, by gender? *:

female:

  1. Pericardial effusion (fluid around the heart)
  2. Tooth disorder (tooth disease)
  3. Weight decreased
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Emotional distress
  6. Foot fracture
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. General physical health deterioration (weak health status)
  9. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  10. Hypercholesterolaemia (high levels of cholesterol in the blood)

male:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Drug ineffective
  3. Arthralgia (joint pain)
  4. Bone disorder
  5. Cardiac disorder
  6. Cellulitis (infection under the skin)
  7. Chest pain
  8. Completed suicide (act of taking one's own life)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Cough

What are the common drug interactions of Naprosyn and Piroxicam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cavernous sinus thrombosis (formation of a blood clot in brain)
  2. Diplopia (double vision)
  3. Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement)
  4. Vith nerve paralysis
  5. Abdominal pain
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Gradenigo's syndrome (complication of middle ear infection)
  8. Headache (pain in head)
  9. Herpes zoster oticus (viral infection of the inner, middle, and external ear caused by varicella-zoster virus (vzv))
  10. Hypotension (abnormally low blood pressure)

20-29:

  1. Anxiety
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Emotional distress
  4. General physical health deterioration (weak health status)
  5. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  6. Injury
  7. Skull fractured base
  8. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  9. Subdural haemorrhage (bleeding between the skull and the surface of the brain)

30-39:

  1. Angioedema (rapid swelling of the dermis)
  2. Face oedema (swelling of face)
  3. Oral pruritus (itching in mouth)
  4. Tongue oedema (swelling of tongue)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  2. Joint contracture (a permanent shortening of a muscle or joint)
  3. Loose tooth
  4. Mood disorder due to a general medical condition
  5. Multiple fractures
  6. Myalgia (muscle pain)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nausea (feeling of having an urge to vomit)
  10. Nephrolithiasis (calculi in the kidneys)

50-59:

  1. Drug ineffective
  2. Ankylosing spondylitis (type of arthritis affecting the spine)
  3. Arthralgia (joint pain)
  4. Chest pain
  5. Completed suicide (act of taking one's own life)
  6. Discomfort
  7. Drug abuse
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Fatigue (feeling of tiredness)
  10. Infection

60+:

  1. Drug hypersensitivity
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hypertension (high blood pressure)
  4. Injury
  5. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  6. Arthralgia (joint pain)
  7. Blood cholesterol increased
  8. Cardiac failure congestive
  9. Congestive (dilated) cardiomyopathy (weakening of dilated heart muscle)
  10. Ejection fraction decreased (systolic heart failure)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 13.16%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.53%
  3. Depression: 4 people, 10.53%
  4. Back Pain: 4 people, 10.53%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 10.53%
  6. Spondyloarthropathy (any joint disease of the vertebral column): 3 people, 7.89%
  7. Ovarian Cysts (fluid filled sacs of the ovary): 3 people, 7.89%
  8. Oedema (fluid collection in tissue): 3 people, 7.89%
  9. Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 3 people, 7.89%
  10. Infection: 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and Piroxicam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naprosyn and Piroxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Piroxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Piroxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on naproxen and piroxicam (the active ingredients of Naprosyn and Piroxicam, respectively), and Naprosyn and Piroxicam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: